Monday, November 21, 2016

BRIEF-Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients

* Rosetta genomics enters research collaboration using

microrna biomarkers to predict response to leading

immuno-oncology drug nivolumab in lung cancer patients

Source text for Eikon:

Further...

Read more

No comments:

Post a Comment